Search research articles
Contact Us
Filters
Showing results (151-160 of 156) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 156 results.
Annals of Hematology
|
May 19, 2022
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'
G Mele, N Cascavilla, N Di Renzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2003
VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study
A Levis, A P Anselmo, A Ambrosetti, et al.
British Journal of Haematology
|
July 23, 2024
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma
A Pinto, M Caltagirone, M Battista, et al.
Leukemia Research
|
February 1, 2015
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese"
G Mele, A Melpignano, G Quarta, et al.
Blood Cancer Journal
|
November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials
A Castellino, A Chiappella, B R LaPlant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2023
Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial
M Ladetto, R Tavarozzi, M Zanni, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 156) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 156 results.
Annals of Hematology
|
May 19, 2022
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'
G Mele, N Cascavilla, N Di Renzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2003
VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study
A Levis, A P Anselmo, A Ambrosetti, et al.
British Journal of Haematology
|
July 23, 2024
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma
A Pinto, M Caltagirone, M Battista, et al.
Leukemia Research
|
February 1, 2015
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese"
G Mele, A Melpignano, G Quarta, et al.
Blood Cancer Journal
|
November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials
A Castellino, A Chiappella, B R LaPlant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2023
Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial
M Ladetto, R Tavarozzi, M Zanni, et al.
Page
of 16